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Abstract
The adhesion G-protein-coupled receptor CD97 is present in normal colonic enterocytes but overexpressed in colorectal
carcinoma. To investigate the function of CD97 in colorectal carcinogenesis, transgenic Tg(villin-CD97) mice overexpressing
CD97 in enterocytes were generated and subjected to azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced colitis-
associated tumorigenesis. Unexpectedly, we found a CD97 cDNA copy number-dependent reduction of DSS-induced colitis
in Tg compared to wild-type (WT) mice that was confirmed by applying a simple DSS protocol. Ultrastructural analysis
revealed that overexpression of CD97 strengthened lateral cell-cell contacts between enterocytes, which, in contrast, were
weakened in CD97 knockout (Ko) mice. Transepithelial resistance was not altered in Tg and Ko mice, indicating that tight
junctions were not affected. In Tg murine and normal human colonic enterocytes as well as in colorectal cell lines CD97 was
localized preferentially in E-cadherin-based adherens junctions. CD97 overexpression upregulated membrane-bound but
not cytoplasmic or nuclear b-catenin and reduced phospho-b-catenin, labeled for degradation. This was associated with
inactivation of glycogen synthase kinase-3b (GSK-3b) and activation of Akt. In summary, CD97 increases the structural
integrity of enterocytic adherens junctions by increasing and stabilizing junctional b-catenin, thereby regulating intestinal
epithelial strength and attenuating experimental colitis.
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Introduction
Intestinal epithelial cells are linked together by a junctional
complex comprising tight and adherens junctions and desmosomes,
providing different functions in cell-cell adhesion. In adherens
junctions (or zonulae adherentes), homophilically interacting E-
cadherin receptors physically link the confronting cell membranes.
At the intracellular membrane face, E-cadherins are connected
through intracellular plaque core proteins, mainly catenins, to
cortical actin filament bundles, organizing a circular adhesion belt
[1,2]. E-cadherin-based adherens junctions contribute crucially to
the organization and stabilization of the polarized intestinal cell
layer. Their dysregulation causes cell depolarization, loss of contact-
dependent inhibitionof proliferation, increasedmotility, leakiness of
the mucosal barrier, and disturbances in enterocytic cell-cell contact
formation – processes that have been linked to colorectal
carcinogenesis [3] and inflammatory bowel disease [4–6]. Addi-
tional complications can arise from the dislocation of membrane-
bound b-catenin, which functions as a nuclear modulator in Wnt
signaling during colorectal carcinogenesis [2].
An increasing number of molecules have been described to be
engaged in the complex regulation of adherens junctions, a
process which is not yet understood in detail [7,8]. Here, we
report CD97 to be located in enterocytic E-cadherin-based
adherens junctions, where it regulates structural integrity by
modulating the anchor protein b-catenin. CD97 is a member of
the epidermal growth factor seven-span transmembrane (EGF-
TM7) family of adhesion G-protein-coupled receptors [9]. Next
to its broad and abundant expression in leukocytes, CD97 is
found in various normal and malignant epithelia. We previously
described its overexpression in colorectal adenocarcinomas
compared to the corresponding normal tissues [10]. Remarkably,
scattered colorectal tumor cells at the tumor-host interface
express significantly more CD97 than cells in solid tumor
formations. Corroborating this observation, CD97 expression
levels correlated with the migratory and invasive capacity of
colorectal tumor cell lines in vitro [10]. CD97 overexpression in
HT1080 human fibrosarcoma cells promoted tumor growth in
scid mice and stimulated single cell motility in vitro in an isoform-
specific manner [11]. In silico simulations suggested that CD97
PLoS ONE | www.plosone.org 1 January 2010 | Volume 5 | Issue 1 | e8507can increase the invasive capacity of tumors and cause the
appearance of scattered tumor cells at the invasion front [11].
To explore directly the hypothesis that CD97 expression affects
colorectal carcinogenesis, we generated transgenic (Tg) mice that
constitutively overexpress CD97 in intestinal epithelial cells. These
CD97 Tg mice were examined in the azoxymethane (AOM)/
dextran sodium sulfate (DSS) model for colitis-associated tumor-
igenesis. Unexpectedly, depending on the CD97 cDNA copy
number integrated, carcinogenesis in Tg mice was reduced due to
impaired DSS-induced injury. Ultrastructural analysis of colonic
enterocytes revealed that lateral cell-cell contacts were strength-
ened in CD97 Tg mice and weakened in CD97 knockout (Ko)
mice. We demonstrate that CD97 is located in E-cadherin-based
adherens junctions and that it regulates membrane-associated b-
catenin associated with alterations in Akt/glycogen synthase
kinase-3b (GSK-3b) signaling.
Materials and Methods
Ethics Statement
This research complied with the ethics guidelines of the
University of Leipzig. For the generation of transgenic mice and
for animal experiments we obtained ethics approval from the
Landesdirektion Leipzig (TVV01/06, TVV23/08). We obtained
ethics approval from the Ethics Committee of the Medical Faculty
of the University of Leipzig (No111-2009) to analyze human
colonic samples and written consent from all participants involved
in this study.
Reagents
Primers and antibodies used in this study are specified in table 1
and 2.
CD97 Tg and CD97 Ko Mice
A villin-CD97 expression construct was generated by placing a
9 kb regulatory region of the mouse villin gene [12] upstream of a
CD97 cDNA. Mouse CD97 cDNA was amplified from a
pcDNA3.1/Zeo(+)-CD97(EGF1,2,3,4) construct [13] using prim-
ers mCD97-s1/mCD97-r1 and subcloned via BsiWI and MluI
restriction sites into the pBS-KS-Villin-MES-SV40-polyA plasmid,
kindly provided by Dr. S. Robine (Institute Curie, Paris, France).
Tg mice were generated by pronuclear microinjection of the
purified expression construct into fertilized oocytes of C57BL/6J
mice (Harlan Winckelmann GmbH, Borchen, Germany). To
establish Tg lines, founders were mated to wild-type (WT)
C57BL/6J mice. WT littermates were used as controls in all
experiments.
The CD97 Ko mouse has been generated recently [14] and was
back-crossed to C57BL/6J mice for eight generations. All mice
were housed under specific pathogen-free conditions at the
Medical Experimental Center of the University of Leipzig.
PCR
Genomic DNA was isolated from tail biopsies. Primers for
amplification of the transgene were villin-s1/mCD97-r2, generat-
ing a 2100 bp PCR product. The copy number was determined in
three mice of each line by quantitative real-time PCR using the
primers villin-s1/mCD97-r3 and a matching external standard
described previously [14].
RNA was isolated with the Qiagen total RNA isolation kits for
normal or fibrous tissue (Qiagen GmbH, Hilden, Germany).
cDNA was synthesized from 1 mg RNA in a 20 ml standard
reaction mixture containing 200 U Superscript II RNaseH-reverse
transcriptase (Invitrogen GmbH, Karlsruhe, Germany). Amplifi-
cation was carried out on a Rotorgene real-time machine (Corbett
Research, Mortlake, Australia) in a total volume of 20 ml
containing 0.5 mM of each primer, 10 ml Power SYBRH Green
PCR kit (Applied Biosystems, Darmstad, Germany), and 1 mlo f
DNA. The PCR primers were mCD97-s2/mCD97-r4 and
mGAPDH-s1/mGAPDH-r1.
CD97 Expression Analysis
The cleaned intestinal mucosa was removed by scratching with
a glass slide. To separate single epithelial cells, the mucosa was
treated for 30 s with Bashing Beads (ZymoResearch, Orange, CA)
and filtered through a 40 mm gaze. Splenocytes were isolated by
Ficoll-density gradient centrifugation. Cells were labeled for CD97
with the biotinylated 1B2 antibody in combination with
streptavidin-phycoerythrin (Invitrogen) and analyzed on a FACS
Star (BD Biosciences, Erembodegem, Belgium).
Immunohistology for murine CD97 was performed as describe
[14].
Intestinal Morphology
Cryostat sections were stained with hematoxylin-eosin (HE).
The thickness of all intestinal layers, the length of the villi and the
depth of the crypts were measured under a light microscope using
the AxioVision program 4.5 (Carl Zeiss MicroImaging GmbH,
Jena, Germany).
Table 1. List of primers.
Name Sequence (59-…-39) Application
mCD97-s1 ccg cgt acg gcc acc atg agg agc gtc cloning
mCD97-r1 tgt cac gcg tgg aac tcg cct tca cat cloning
villin-s1 tgc ctt ctc ctc tag gct cgt amplification of the transgene, copy number determination
mCD97-r2 ggg cga tgg cgg tga tgg tc amplification of the transgene
mCD97-r3 aaa gtc tcc aca gga aaa tcc copy number determination
mCD97-s2 cct ggt cgg cgt gga gaa tga ag real-time PCR mouse tissues
mCD97-r4 ggg cga tgg cgg tga tgg tc real-time PCR mouse tissues
mGAPDH-s1 tcc acc acc ctg ttg ctg ta real-time PCR mouse tissues
mGAPDH-r1 acc aca gtc cat gcc atc ac real-time PCR mouse tissues
doi:10.1371/journal.pone.0008507.t001
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In the AOM/DSS model 8–10 week old Tg and WT mice
(n=16/group) of both sexes were injected i.p. with 10 mg AOM
(Sigma-Aldrich, Taufkirchen, Germany)/kg body weight. After
one week, 2.5% DSS (MP Biomedicals, Eschwege, Germany) was
added to the drinking water for 5 days, followed by 2 weeks of
ordinary tap water. This cycle was repeated three times. Control
mice (n=6/group) were given water without DSS. Mice were
killed 8 weeks after termination of the last cycle.
In the DSS model 8–10 week old mice (n=8/group/time point
of termination) of both sexes received 2.5% DSS in the drinking
water for 5 days, followed by ordinary tap water. Mice were killed
4, 7, or 27 days after initiation of the experiment.
Our recently generated CD97 Ko mice [14] were not examined
in the colitis models. Neutrophilic granulocytes that influence
strongly the extent and severity of colitis strongly express CD97
[14]. Thus, CD97 Ko mice would mainly reflect the influence of
CD97 on leukocytic infiltration in DSS-induced injury.
In the both models, clinical evaluation included daily monitor-
ing of body weight, fecal blood, and diarrhea. Each parameter was
scored in the disease activity index on a scale of 0–4, with 4
correlating with the most severe clinical disease [15]. After killing
the mice, colon length and weight were recorded to determine the
extent of shortening and intestinal edema. In addition, the weight
of the spleen and mesenteric lymph nodes was determined. In the
simple DSS model, gut tissue was collected for histological analysis
and measurement of transepithelial resistance.
For microscopic evaluation, colonic tissue specimens were snap-
frozen in liquid nitrogen and stained with hematoxylin-eosin (HE).
Severity, extent of inflammation, and crypt damage were judged
together with the percentage of involvement in the colon as described
[16]. The maximum histological score was 40. Granulocytes were
stained for myeloperoxidase by standard immunohistology.
Whole Colon Culture and ELISA
100 mg of distal colon was cut into small pieces and cultured in
12-well culture plates with 2 ml serum-free RPMI. A high
concentration of penicillin/streptomycin was supplemented to
prevent bacteria growth. After incubation at 37uC for 24 h,
supernatants were collected and examined for chemokine
production with ELISA kits (R&D Systems GmbH, Wiesbaden,
Germany).
Electron Microscopy
Mice were analyzed at the age of 3 months. Samples of the
small and large bowel (n=3 of each mouse line) of about 1 mm
3
were rapidly collected and fixed in cold buffered Karnovsky’s
solution/2% glutardialdehyde/2% paraformaldehyde (pH 7.4) for
2 h. Samples were contrasted with osmiumtetroxide and phos-
photungstic acid and embedded after dehydration in Durcupan
(Fluka Chemie AG, Buchs, Switzerland). Ultrathin sections were
contrasted with uranyl acetate and lead citrate solution. Repre-
sentative electron micrographs were captured using an EM 900
(Carl Zeiss Meditec, Oberkochen, Germany).
Ussing Chamber Studies
Distal colonic tissue specimens were mounted in modified
Ussing chambers and transepithelial resistance was recorded [17].
Laser-Scanning Microscopy
Caco-2, SW-480, Widr, DLD-1, and Hek293 cells were
obtained from The American Type Culture Collection (ATCC,
Manassas, USA). HT-29/B6 cells were cultured as described [18].
CD97 was co-localized in the cell lines and in the mouse intestine
with antibodies to junctional proteins by laser-scanning microsco-
py [14]. To examine the role of F-actin, cells were treated with
0.2 mM cytochalasin D (Sigma), an inhibitor of actin polymeriza-
Table 2. List of antibodies.
Antigen Species specificity Origin Clone Company/reference
CD97, a-chain mouse hamster monoclonal 1B2 [13]
CD97, a-chain mouse goat polyclonal R&D Systems, Wiesbaden, Germany; [14]
CD97, b-chain mouse rabbit polyclonal [14]
CD97, a-chain human mouse monoclonal CLB-CD97/3 [36]
CD97, a-chain (aa 220–270) human rabbit polyclonal Imgenex, San Diego, USA
myeloperoxidase mouse rabbit polyclonal GeneTex Inc., San Antonio, USA
a-catenin mouse/human rabbit polyclonal GeneTex Inc
a-tubulin mouse/human mouse monoclonal DM1A Sigma-Aldrich, Taufkirchen, Germany
b-catenin mouse/human rabbit polyclonal Santa Cruz
phospho-b catenin (Ser33/Ser37) mouse/human mouse monoclonal BC-22 Santa Cruz
E-cadherin mouse/human rat monoclonal DECMA-1 Abcam, Cambridge, UK
EpCAM mouse rat monoclonal G8.8 BD Biosciences, Heidelberg, Germany
desmoplakin mouse/human rabbit polyclonal Santa Cruz, Heidelberg, Germany
H3 histone mouse/human rabbit monoclonal E173-58 Epitomics Inc., Burlingame, USA
p120 catenin mouse/human rabbit polyclonal Santa Cruz
ZO-1 mouse/human rabbit polyclonal Invitrogen GmbH, Karlsruhe, Germany
Akt-1 mouse/human rabbit monoclonal C73H10 New England Biolabs GmbH, Frankfurt,
Germany
phospho-Akt (Ser 473) mouse/human rabbit polyclonal New England Biolabs
phospho-GSK-3b (Ser 9) mouse/human rabbit polyclonal New England Biolabs
doi:10.1371/journal.pone.0008507.t002
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AlexaFluor 564-coupled phalloidin (Invitrogen GmbH, Karlsruhe,
Germany).
Human Colon Specimens
Paraffin sections of inflamed colonic specimens from patients
with ulcerative colitis with mild to moderate macroscopic disease
activity (n=5) were stained with a CD97 a-chain-specific
polyclonal antibody (Imgenex, San Diego, CA) by immunohistol-
ogy after antigen retrieval (citrate buffer, pH 6.0). Control
specimens were taken from patients undergoing resection of
sigmoidal or rectal cancer (n=5).
Immunochemical Analyses
Western blotting was performed as described [14]. Cells or
tissues were lysed in M-PER or T-PER lysis buffer containing
Halt
TM protease inhibitor cocktail (Thermo Fisher Scientific,
Bonn, Germany). The ProteoJET
TM membrane protein and
cytoplasmic/nuclear protein extraction kits (Fermentas GmbH, St.
Leon-Rot, Germany) were used to isolate membrane, cytoplasmic
and nuclear proteins.
Custom Kinetworks KCPS multiimmunoblotting analyses were
performed using 300 mg of colonic lysate proteins of CD97 Ko,
WT and Tg1 mice as described [19].
Statistical Analysis
Where applicable, data are expressed as mean 6 SEM.
Statistical analysis was performed using the Student’s t-test.
p,0.05 was considered significant.
Results
CD97 Tg Mice Constitutively Overexpress CD97 in
Intestinal Epithelial Cells
To study the consequences of constitutive expression of CD97
in intestinal epithelial cells, we generated Tg(villin-CD97) mice
expressing full-length CD97 with all four EGF-like domains under
control of the villin promotor [12] (fig. 1a). Ten independent
founders were identified that had integrated the CD97 transgene.
By mating with WT mice, three lines were established, designated
CD97 Tg1, CD97 Tg2, and CD97 Tg3 (in short, Tg1 to Tg3).
The copy number of the CD97 transgene in the genome of these
lines was calculated using real-time PCR. Tg1 had integrated
approximately 10–15 copies, Tg2 70–80 copies, and Tg3 nearly
400 copies (fig. 1b).
Monitoring of reproductive performance revealed an impaired
fitness in the Tg mice that correlated with the CD97 cDNA copy
number integrated (fig. 1c) and that presumably was due to
overexpression of CD97 in villin-positive cells in the female and
male reproductive tracts [20]. Tg3 was difficult to breed and could
not be characterized in detail in this study.
Expression of CD97 in the small and large intestine is generally
low in WT mice as compared to tissues like spleen and lung [14].
Transcription of the villin-driven transgene in the intestines
resulted in a copy-number dependent increase in CD97 mRNA
in the Tg mice up to 150 times-fold higher than that observed in
WT mice (fig. 1d). In contrast, no change in CD97 mRNA levels
was observed in spleen and lung. At the protein level, isolated
intestinal cells of the small (fig. 1e) and large bowel were strongly
CD97 positive in Tg but negative in WT mice. Moreover,
immunohistology revealed strong CD97 expression in the
epithelial layer of the small and large intestine, while in WT
animals these cells were CD97 negative (fig. 1f). CD97 staining of
villin-positive cells was stronger in Tg2 mice compared to Tg1
mice, indicating that also at the protein level, CD97 expression
correlated with the number of CD97 cDNA copies integrated
(fig. 1f).
Western blot analysis of small bowel lysates with a CD97 a-
chain-specific antibody revealed a strong signal at approximately
85 kDa only in Tg mice (fig. 1g). The band corresponded to the
predicted size of full-length CD97(EGF1,2,3,4). In the spleen, two
bands were visible in both WT and Tg mice, and are likely to
represent CD97(EGF1,2,3,4) and the smaller isoform
CD97(EGF1,2,4). Signals for the CD97 b-chain at 28 kDa were
obtained in the spleen of WT and Tg mice but only in the small
intestine of Tg animals.
Microscopic investigation of intestinal morphology showed no
changes in Tg mice as compared to WT mice (data not shown).
CD97 Tg Mice Are Protected against DSS-Induced Colitis
CD97 Tg mice were examined in the AOM/DSS model for
colitis-associated tumorigenesis. Three cycles of AOM/DSS were
administered (fig. 2a). All AOM/DSS treated mice, irrespective of
the genotype, developed colorectal cancer. Intestinal CD97
overexpression decreased the number of tumors in the colon
significantly in the Tg2 line and caused a trend toward fewer
tumors in Tg1 mice (fig. 2b). During the first treatment cycle,
application of DSS induced severe acute colitis in WT mice as
judged by the assessment of body weight, fecal blood, and
diarrhea. Surprisingly, disease activity was significantly reduced in
both Tg(villin-CD97) lines. Each of the single parameters scored
for the disease activity index was decreased in Tg compared to
WT mice, thereby displaying a correlation with CD97 cDNA copy
number (fig. 2c–f).
Thus, we decided to focus our investigation on the effects of
CD97 overexpression on the function of the intestinal epithelium.
A simple DSS model unambiguously confirmed the protective
effect of CD97 overexpression in intestinal cells (fig. 3a).
Histological scoring of the colon revealed more crypt damage
and a markedly higher degree and extent of inflammation in DSS-
treated WT mice compared to Tg mice (fig. 3b, c). Tg2 mice even
had no signs of epithelial injury and inflammation at day 4 and
only low activity at day 7. Quantitation of myeloperoxidase-
positive cells, infiltrating into the distal colon, showed higher
numbers of neutrophils in WT compared to Tg mice (fig. 3b).
Epithelial damage and inflammation was mainly restricted to the
distal part of the colon in all mice. Inflammatory cytokines as
CXCL1 (KC), CXCL2 (MIP-2) and CCL2 (MCP-1) were clearly
induced to much higher amounts in whole colon cultures of WT
compared to Tg mice as exemplarily shown here for CXCL1
(fig. 3d). Colon shortening as a hallmark of DSS-induced damage
was reduced in Tg compared to WT mice (fig. 3e). Finally, local
and systemic activation of the immune system, illustrated by
enlargement of the spleen and mesenteric lymph nodes, was
markedly reduced in Tg mice (fig. 3f).
Anchoring Cell Junctions Are Strengthened in CD97 Tg
but Weakened in CD97 Ko Mice
As morphology of the intestinal epithelium in CD97 Tg mice
was normal at the microscopic level, we tested the possibility that
CD97 increases the stability of lateral cell-cell contacts by
ultrastructural analysis. Enterocytes of Tg mice appeared to be
well polarized with apical membranes bearing characteristic
microvilli (fig. 4a). Examining cell junctions, including the
luminally localized tight junctions and the more basally localized
adherens junctions, revealed that the latter anchoring contacts
were strengthened in Tg mice (fig. 4a). Especially the cytoplasmic
site of the junctions, characterized by a plate-like densification or
CD97 Attenuates Colitis
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condensed. Here, microfilaments were extremely prominent and
appeared to be continuous with the bundles of filaments that
encircle the cytoplasmic surface of the contact region, building the
adhesion belt of the enterocytes. In contrast, in CD97-deficient
mice, adherens junctions were weakened. Here, the bundles of
filaments nearly disappeared whereas tight junctions seemed to be
well arranged (fig. 4a).
Figure 1. Generation of CD97 Tg mice that overexpress CD97 in intestinal cells. A Schematic representation of the pBS-KS-Villin-CD97
construct showing the villin promoter region (hatched box), the mouse CD97 cDNA containing EGF-like domains 1 to 4, and the SV40
polyadenylation sequence (dotted box). B Three CD97 Tg lines with different CD97 cDNA copy numbers were established (n=3 mice/line, mean 6
SEM). C CD97 Tg mice showed impaired reproductive performance. The number of births per mating pair correlated inversely with the CD97 cDNA
copy number integrated (n=6 mating pairs over 4 months). The percentage of stillbirths dramatically increased in the Tg3 line. The number of pups
per birth was comparable between Tg and WT mice. (***, p,0.001). D Quantitative RT-PCR of tissues from WT and Tg mice. Tissues with a high
percentage of villin-positive cells as the small and large intestine expressed high levels of CD97 mRNA in Tg mice. E Flow-cytometric analysis revealed
comparable levels of CD97 expression in splenic lymphocytes of WT and Tg mice. In contrast, enterocytes were CD97 negative in WT but strongly
CD97 positive in Tg2 mice. F CD97 immunostaining (c=negative control) of tissues of WT (a, c, e) and Tg (b, d, f) mice. In WT colon (a), cells of the
lamina propria mucosae (arrow) were stained whereas in the colon of Tg1 (b) and Tg2 (d) mice, epithelial cells were CD97 positive. The muscular coat
(asterisk) slightly stained for CD97. In the spleen (e, f), leukocytes equally expressed CD97 in WT and Tg mice. Scale bar=50 mm. G Western blot
analysis of CD97 with a- and b-chain-specific antibodies revealed strong signals in the small intestine of Tg1 but not WT mice. In the spleen, CD97 was
detected in WT and Tg mice. Two bands at 80 and 85 kDa, derived from the a-chain-specific antibody, probably present alternatively spliced CD97
isoforms.
doi:10.1371/journal.pone.0008507.g001
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which crucially depends on tight but not adherens junctions,
Ussing chamber experiments were performed. Transepithelial
resistance was comparable in the distal colon and ileum (data not
shown) of untreated WT, Tg, and Ko mice (fig. 4b). Also after
DSS treatment, no differences in transepithelial resistance were
observed between Tg and WT mice (fig. 4c).
CD97 Co-Localizes with Adherens Junction Proteins
To further explore a potential link between the expression of
CD97 and the formation of adherens junctions, we applied
double-immunostaining in combination with laser scanning
microscopy. In colon sections of Tg mice, CD97 co-localized
with the adhesive receptor E-cadherin (fig. 5a) and the anchor
protein b-catenin (data not shown), two key constituents of
adherens junctions. In contrast, little co-localization was found
with the tight junction proteins ZO-1 (fig. 5a) and occludin (data
not shown) and with the desmosom protein desmoplakin.
Staining of HT29/B6 human colorectal carcinoma cells showed
consistent expression of CD97 along the lateral cell membrane, where
it co-localized with b-catenin but not with ZO-1 and desmoplakin
(fig. 5b). Co-localization of CD97 with b-catenin was confirmed in
other colorectal cell lines that highly express CD97 at the cell surface
[10] such as SW-480, Caco-2, DLD-1, and Widr (data not shown).
CD97 staining indicated that the molecule might be involved in
the anchoring of cadherin family adhesive receptors to the actin
filaments of the cytoskeletal network. We found partial co-staining
for CD97 and cortical F-actin (fig. 5c). To test whether F-actin
regulates the subcellular localization of CD97, we treated HT29/
B6 cells with cytochalasin D. As a consequence, F-actin became
disorganized and lost its membrane localization. However, the
membrane association of CD97 was preserved and only
disappeared in cells with a totally disorganized cytoskeleton
(fig. 5c) suggesting that CD97 is not likely to couple to F-actin
by a direct physical interaction.
We continued our investigation by examining the subcellular
localization of CD97 in human colonic enterocytes. Immuno-
staining of paraffin sections of normal colon detected CD97 at
lateral cell-cell contacts akin to the distribution of b-catenin
(fig. 5d). In colonic biopsies of ulcerative colitis patients,
enterocytes were CD97 positive, preferentially in the cytoplasm.
Staining at lateral cell-cell junctions was observed only in one
out of five patients, indicating the loss of CD97 in such cell
contacts in ulcerative colitis. A similar disorganization was
observed for b- c a t e n i n( f i g .5 d ) .Q u a n t i t a t i o no fC D 9 7i n
ulcerative colitis by Western blot analysis was hampered by the
high expression of the molecule on accumulating inflammatory
leukocytes.
Figure 2. CD97 Tg mice are protected from colitis in the AOM/DSS model. A Treatment protocol: Mice underwent three cycles
of AOM/DSS treatment (n=16/group). B Intestinal CD97 overexpression changed the number of tumors in the colon of Tg mice (*, p,0.05).
C–F Disease activity index (DAI) and separate scores of this index during the first treatment cycle causing acute colitis in WT animals. Disease
activity (C), fecal blood (D), diarrhea (E), and weight loss (F) were strongly reduced in Tg mice. Lowest disease activity was found in Tg2
mice.
doi:10.1371/journal.pone.0008507.g002
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Signaling
We next investigated whether CD97 modulates the expression
of proteins that form adherens junctions. In colonic lysates, the
amount of the adhesion receptor E-cadherin was not affected in
Tg and Ko mice (fig. 6a). In contrast, expression of the plaque-
building proteins a-catenin, b-catenin, and p120-catenin was
enhanced in Tg mice and decreased in Ko mice as compared to
WT animals.
Next to the majority of b-catenin that is bound to the
intracellular domain of E-cadherin, a cytoplasmic pool exists that
is degraded after phosphorylation [21]. Increased levels of
cytoplasmic b-catenin can accumulate and become available for
nuclear translocation and binding to T-cell factor (TCF) DNA-
binding proteins, resulting in gene transcription. By extracting
membrane, cytoplasmic, and nuclear proteins, we could show that
CD97 overexpression specifically causes accumulation of mem-
brane-associated b-catenin while the amount of cytosolic and
nuclear b-catenin was not affected and rather low (fig. 6b).
Cellular levels of b-catenin are regulated through phosphory-
lation by GSK-3b at Ser 33/37 leading to proteasomal
degradation [21]. Interestingly, CD97 overexpression decreased
phospho-b-catenin in Tg compared to WT mice. Highest levels of
p-b-catenin were found in Ko mice, where probably most of the
Figure 3. CD97 Tg mice show reduced clinical and microscopic signs of DSS-induced colitis. A Treatment protocol: Mice were killed at
days 4, 7, or 27 after initiation of the experiment (n=8/group/time point of termination). Shown here is the disease activity index (DAI) of mice that
stayed in the experiment for 27 days. B Crypt damage and inflammation of the distal colon was strongly reduced in Tg2 (b, d) compared to WT mice
(a, c) at day 7. Only few neutrophils (arrow) were detected in the distal colon of Tg mice. HE- (a, b) and myeloperoxidase- (c, d) stained sections; scale
bar=20 mm. C Histological examination at days 4 and 7 revealed gradually lowered colitis in Tg mice depending on the CD97 cDNA copy number
integrated (*, p,0.05; **, p,0.01). D Decreased secretion of CXCL1 in whole colon cultures of Tg mice at day 7 (*, p,0.05). E Colon shortening as a
hallmark of DSS-induced damage was stronger in WT compared to Tg mice at days 4, 7, and 27 (*, p,0.05; **, p,0.01). F Increase in spleen and
mesenteric lymph node weight as signs of local and systemic activation of the immune system were reduced in Tg mice at days 4, 7, and 27
(*, p,0.05).
doi:10.1371/journal.pone.0008507.g003
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tion of b-catenin inversely correlated with the amount of CD97,
indicating that CD97 stabilizes b-catenin and increases its level in
adherens junctions. Our data suggest an inactivation of GSK-3b,
which occurs by phosphorylation through different kinases
[22,23]. Indeed, quantitation of phospho-GSK-3b (Ser9) revealed
its increase in Tg2 compared to WT mice. Our data further
suggest that GSK-3b is inactivated by Akt, known as protein
kinase B (PKB), a serine/threonine kinase that is fully activated
following its phosphorylation [8]. We found an upregulation of
total Akt in Tg compared to WT and Ko mice combined with
detectable p-Akt (Ser473) in Tg1 and Tg2 mice (fig. 6c). This result
was confirmed by multiimmunoblotting analysis of colonic lysates
of CD97 Ko, WT and Tg1 mice: one out of the two proteins
exhibiting phosphorylation changes of greater than 300% between
WT and Tg1 mice was p-Akt (Ser473; signal intensity CD97 Ko:
217, WT: 180; Tg1: 614 arbitrary units). Phosphorylation of Akt at
tyrosine 308 was only detectable in Tg1 lysates (signal intensity
Tg1: 78 arbitrary units).
Discussion
We here demonstrate a novel role of the adhesion G-protein-
coupled receptor CD97 in regulating intestinal epithelial cell
function. By comparing CD97 Tg mice that constitutively
overexpress CD97 in intestinal epithelial cells to WT animals
and to mice that lack a functional Cd97 gene, we obtained
evidence that CD97 controls the structure of enterocytic adherens
junctions and thereby the integrity of the intestinal barrier.
We first made these observations when subjecting CD97 Tg
mice to AOM treatment combined with DSS in order to study the
effect of CD97 on tumorigenesis. DSS causes destruction of the
epithelial cells in the basal crypts and induce an inflammatory
reaction in the colonic mucosa that acts as a promoter of colorectal
carcinogenesis [24,25]. Unexpectedly, we found a reduction of
tumor numbers in Tg mice that was caused by amelioration of
DSS-induced injury. Protection of CD97 Tg mice from DSS colitis
was reproduced by treatment with DSS alone and involved lower
clinical disease activity, less histological crypt damage, and
reduced local and systemic immune reactivity.
The finding that CD97 overexpression attenuated colitis and
the fact that this amelioration correlated with the CD97 cDNA
copy number integrated in the Tg mice indicated that CD97 can
regulate epithelial cell function. Integrity and stability of the
intestinal epithelium is maintained by different types of specialized
cell contacts. Immunohistochemistry revealed co-localization of
CD97 with proteins of E-cadherin-based adherens junctions in
murine as well as human colonic enterocytes and colorectal cell
lines. In addition, electron microscopy studies showed that these
basally localized cell-cell junctions were strengthened in CD97 Tg
mice and weakened in CD97 Ko mice.
The formation and stabilization of adherens junctions requires
the recruitment of cytosolic b-catenin to the plasma membrane
and its tight association with E-cadherin [8]. We found evidence
that CD97 can regulate the localization and stability of b-catenin
in enterocytes. Firstly, CD97 expression levels correlated with the
amount of non-phosphorylated, stable b-catenin. Secondly, the
amount of p-Akt (Ser473) and p-GSK-3b was regulated
consistently and reversely in Ko and Tg compared to WT mice,
indicating that Akt/GSK-3b signaling is involved in the
stabilization of b-catenin through CD97. Akt phosphorylates the
N-terminus of GSK-3b thereby inhibiting the ability of GSK-3b to
phosphorylate b-catenin [8]. Because phosphorylation of b-
catenin initiates its ubiquitination and degradation in the
proteasome, phosphorylation of GSK-3b may explain the
accumulation of membranous non-phosphorylated b-catenin in
Tg enterocytes.
In tumor cells, a different distribution of b-catenin is found. Here,
accumulation of b-catenin caused by mutations in the adenomatous
polyposis coli (Apc) gene, involved in the intracellular transport of b-
catenin [26], or in the genes encoding axin and b-catenin leads to
translocation of b-catenin into the nucleus, where it induces genes
critical for cell transformation and cancer [27]. It becomes
increasingly clear that the junctional, cytoplasmic and nuclear pools
of b-catenin are closely connected [2]. In our study we identified
CD97 to regulate the membrane-associated pool of b-catenin.
The observations that CD97 overexpression enhances the
strength of enterocytic adherens junctions and increases random
tumor cell migration [11] seem to be contradictory. We have
evidence that Akt signaling is involved in both the CD97-induced
strengthening of adherens junctions and in the migration of tumor
cells: specific inhibitors of the phosphoinositide-3 kinase (PIK3)/
Akt pathway stopped CD97-induced random tumor migration
[28]. The possibility of a dual role of CD97 is supported by a
recent study demonstrating Akt signaling in E-cadherin-based
adherens junction formation as well as in tumor cell migration [8].
Of note is the fact that CD97 is not restricted to adherens
junctions. Peripheral blood leukocytes bear the molecule evenly
distributed at their surface [29,30]. In addition, carcinomas also
show intracellular cytoplasmic staining for CD97 [10,31]. In
migratory, CD97-overexpressing HT1080 cells, the molecule was
Figure 4. Overexpression of CD97 strengthens apicolateral
cell-cell contacts between enterocytes. A Examination by electron
microscopy revealed a correlation between CD97 expression and the
formation of cell-cell junctions (arrows). In CD97 Tg mice especially the
cytoplasmic sites of the contacts were condensed, and microfilaments
were pronounced. Upper images, scale bar=1 mm; lower images, scale
bar=0.25 mm. B Transepithelial resistance in the distal colon was
comparable between untreated WT, Tg, and Ko mice (n=4). C
Transepithelial resistance remained comparable between WT and Tg
mice after 4, 7, and 27 days of DSS-treatment (n=4).
doi:10.1371/journal.pone.0008507.g004
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cortical F-actin [28]. Accordingly, membrane ruffles of migrating
tumor fibroblasts were b-catenin positive [32]. All these data
indicate that CD97 is found in different cellular pools where it
might engage with additional molecular processes.
Adherens junctions crucially contribute to the organization and
stabilization of a polarized intestinal epithelium and their
dysregulation has been linked causally to inflammatory bowel
disease [4–6]. To our knowledge, the CD97 Tg mouse is the first
genetic model, in which adherens junctions are strengthened and
intestinal barrier function is augmented. Interestingly, a suscepti-
bility locus for inflammatory bowel disease has been found in close
proximity to the EGF-TM7 gene cluster on chromosome 19p13
[33,34]. In addition, association of a single nucleotide polymor-
phism in the CD97 promotor (T64C) was associated with
ulcerative colitis [35]. Although these findings need further
confirmation, they may indicate a role of EGF-TM7 receptors
in inflammatory bowel disease. By analyzing colonic biopsies of
ulcerative colitis patients, we observed a loss of CD97 from
enterocytic adherens junctions in 4 out of 5 patients. Whether this
was due to the ongoing disintegration of the tissue or indicates the
involvement of CD97 in the disease process remains to be shown.
In summary, by establishing CD97 Tg mice and examining them
in tumor- and colitis-associated models we identified a novel, yet
unknown function of the adhesion G-protein-coupled receptor
CD97. CD97 regulated plaque core proteins of adherens junctions
in colonic enterocytes. CD97 overexpression strengthened these cell
contacts, which results in an increased epithelial integrity and
decreased experimental colitis sensitivity. Moreover, for the first
time key molecules of intracellular signaling via an EGF-TM7
receptor were identified. Our data suggest that CD97 induces Akt/
GSK-3b signaling that results in a decrease of proteolytic digestion
of b-catenin and its stabilization in adherens junctions. Our data are
confirmed by the reverse results obtained in Ko mice.
Figure 5. CD97 is localized in adherens junctions. A CD97 (green) was concentrated at the apicolateral region of colonic enterocytes of Tg mice
as shown by doublestaining with the epithelial cell marker EpCAM (red). CD97 co-localized with the adherens junction receptor E-cadherin. In
contrast, ZO-1 and desmoplakin as marker for tight junctions and desmosomes, respectively, showed only partial co-localization with CD97. Scale
bar=10 mm. B In polarized HT-29/B6 human colorectal carcinoma cells, CD97 co-localized with b-catenin but not with ZO-1 or desmoplakin.
Photographs for ZO-1 co-staining were taken from the most apical part of the cells. Scale bar=10 mm. C (a) Immunostaining of HT29/B6 cells for
CD97 (green) showed partial co-localization in the lateral cell-cell contacts with cortical F-actin (red). (b) F-actin disappeared after destruction by
cytochalasin while CD97 remained partly in the cortical belt (arrow, cell-cell contacts). Scale bar=10 mm. D In human colonic enterocytes, CD97 had a
similar distribution as b-catenin in lateral cell contacts. In biopsies of ulcerative colitis, CD97 expression at cell-cell contacts was partly lost. Infiltrating
leukocytes strongly expressed CD97. Scale bar=20 mm (a, b, e, f) or 10 mm (c, d, g, h).
doi:10.1371/journal.pone.0008507.g005
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